TMAO compound may play role in cardiovascular disease risk

04/26/2013 | WebMD

Individuals with the highest levels of trimethylamine-N-oxide, a compound produced in the stomach, were 2.5 times more likely to suffer a heart attack, stroke or heart disease than those with the lowest TMAO levels, a study showed. The compound can make it more difficult for the liver and intestines to remove cholesterol, lead researcher Dr. Stanley Hazen of the Cleveland Clinic said. The findings were published in the New England Journal of Medicine.

View Full Article in:

WebMD

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY